HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
|
25077900 |
2014 |
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
|
22927827 |
2012 |
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development.
|
22416012 |
2012 |
Kallmann Syndrome
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
|
22927827 |
2012 |
Kallmann Syndrome
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
By analyzing protein expression and processing, we did not observe any differences of the p.I668V variant compared with wild-type SEMA3A, while a pathogenic SEMA3A variant p.R66W recently described in a patient with Kallmann syndrome did affect protein secretion.
|
29432577 |
2018 |
Malignant neoplasm of breast
|
0.320 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Alcoholic Intoxication, Chronic
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression.
|
29071344 |
2017 |
Major Depressive Disorder
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
SEMA3A variation is significantly and replicably associated with comorbid AD and MD in African American participants.
|
29071344 |
2017 |
Major Depressive Disorder
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression.
|
29071344 |
2017 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
In summary, mutant SEMA3A is a vascular normalizing agent that can be exploited to treat cancer and, potentially, other diseases characterized by pathological angiogenesis.
|
29794061 |
2018 |
Delayed Puberty
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Alcohol-Related Disorders
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression.
|
29071344 |
2017 |
Alcohol-Induced Disorders
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression.
|
29071344 |
2017 |
Waist Circumference
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits.
|
28552196 |
2017 |
Primary malignant neoplasm
|
0.090 |
GeneticVariation
|
group |
BEFREE |
In summary, mutant SEMA3A is a vascular normalizing agent that can be exploited to treat cancer and, potentially, other diseases characterized by pathological angiogenesis.
|
29794061 |
2018 |
Tumor Cell Invasion
|
0.070 |
GeneticVariation
|
phenotype |
BEFREE |
We discovered, among other novel somatic variants in axon guidance pathway genes, a novel mutation in the PLXNA1 receptor (c.2587G>A) in newly established cell line SB.06 that mediates oncogenic cues of increased invasion and proliferation in SB.06 cells and increased invasion in 293T cells upon stimulation with the receptor's natural ligand semaphorin 3A compared to wild type PLXNA1 cells.
|
26962861 |
2016 |
Hirschsprung Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
The genotypes of two SNPs (rs7804122 and rs797821) in the SEMA3A gene in 119 patients with HSCR and 93 controls were examined using PCR-sequencing to determine the contribution of SEMA3A to the HSCR phenotype.
|
22184102 |
2012 |
Hirschsprung Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Recently, genetic markers within a locus on 7q21.11 containing the SEMA3A, SEMA3C, and SEMA3D genes were reported to be associated with Hirschsprung disease (HSCR).
|
27469503 |
2016 |
Degenerative polyarthritis
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
We have previously shown that the mutations p.R116W and p.C299S, associated with MED and SEMD, respectively, cause retention of matrilin-3 within the endoplasmic reticulum of primary chondrocytes, while the mutation associated with osteoarthritis, p.T298M, does not hinder secretion.
|
20077500 |
2010 |
Myocardial Infarction
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Whilst infarct sizes were similar 14 days after myocardial infarction in both genotypes, Sema3A HZ mice had thinner infarcts and reduced cardiac function as compared to their WT littermates.
|
28540528 |
2017 |
Motor Neuron Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Using a mouse model expressing a mutant SEMA3A with diminished signaling capacity, we studied the influence of SEMA3A signaling at the NMJ with two denervation paradigms; a motor neuron disease model (the G93A-hSOD1 ALS mouse line) and an injury model (BotoxA-induced paralysis).
|
28103314 |
2017 |
Autistic Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Expression of several genes associated with schizophrenia or autism including Sema3a, Trfr2 and Vldlr were found to be altered as were protein levels of Foxp2.
|
18248790 |
2008 |
Ehlers-Danlos Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Pathogenic variants in B3GALT6 have also been shown to cause Ehlers-Danlos syndrome spondylodysplastic type (spEDS-B3GALT6) and spondyloepimetaphyseal dysplasia with joint laxity type I (SEMD-JL1).
|
29443383 |
2018 |
Cardiac Arrest
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A high incidence of SEMA3A(I334V) in UCA patients and inappropriate innervation patterning in their hearts implicate involvement of the SEMA3A gene in the pathogenesis of UCA.
|
23593010 |
2013 |
Kaposi Sarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Three heterozygous variants (c.458A>G (p.Asn153Ser), c.1253A>G (p.Asn418Ser), and c.1303G>A (p.Val435Ile)) were found in SEMA3A in three KS patients, two of which also had a mutation in FGFR1.
|
24522099 |
2014 |